chr2-71658981-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 7P and 2B. PM1PM2PM5PP3BP4_Moderate
The NM_001130987.2(DYSF):c.4859G>A(p.Arg1620His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000738 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1620C) has been classified as Pathogenic.
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.4859G>A | p.Arg1620His | missense_variant | 44/56 | ENST00000410020.8 | NP_001124459.1 | |
DYSF | NM_003494.4 | c.4742G>A | p.Arg1581His | missense_variant | 43/55 | ENST00000258104.8 | NP_003485.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000410020.8 | c.4859G>A | p.Arg1620His | missense_variant | 44/56 | 1 | NM_001130987.2 | ENSP00000386881 | A1 | |
DYSF | ENST00000258104.8 | c.4742G>A | p.Arg1581His | missense_variant | 43/55 | 1 | NM_003494.4 | ENSP00000258104 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000717 AC: 109AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000557 AC: 140AN: 251468Hom.: 0 AF XY: 0.000522 AC XY: 71AN XY: 135902
GnomAD4 exome AF: 0.000741 AC: 1083AN: 1461874Hom.: 0 Cov.: 31 AF XY: 0.000714 AC XY: 519AN XY: 727236
GnomAD4 genome AF: 0.000716 AC: 109AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.000605 AC XY: 45AN XY: 74430
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 04, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 27, 2023 | BS1 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 20, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 21, 2021 | This variant is associated with the following publications: (PMID: 12796534, 25868377, 26077327, 17512949, 30564623, 24438169, 30107846) - |
Qualitative or quantitative defects of dysferlin Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Limb-girdle muscular dystrophy, recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | The c.4742G>A (p.Arg1581His) variant as identified in a compound heterozygous state with a second missense variant in one female Korean patient with limb-girdle muscular dystrophy (Shin et al. 2015). Control data are unavailable for this variant, which is reported at a frequency of 0.00358 in the East Asian population of the Exome Aggregation Consortium. The evidence for this variant is limited. The p.Arg1581His variant is classified as a variant of unknown significance but suspicious for pathogenicity for the recessive form of limb-girdle muscular dystrophy. - |
Miyoshi myopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 27, 2022 | Variant summary: DYSF c.4742G>A (p.Arg1581His) results in a non-conservative amino acid change located in the C2 domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00056 in 251468 control chromosomes, predominantly at a frequency of 0.0034 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 1.1 fold of the estimated maximal expected allele frequency for a pathogenic variant in DYSF causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive phenotype (0.0031), suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. c.4742G>A has been reported in the literature in individuals affected with Autosomal Recessive Limb-Girdle Muscular Dystrophy, however in some cases its association with the disease is less clear due to the presence of other variants of uncertain significance in cis, a lack of variants detected in trans, or its presence in healthy controls (example Takahashi_2003, Shin_2015, Nallamilli_2018, Wang_2018). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (VUS n=4, likely benign n=2, pathogenic n=1). Based on the evidence outlined above, the variant was classified as likely benign. - |
DYSF-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 18, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at